Wedbush Securities Inc Abbott Laboratories Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

A detailed history of Wedbush Securities Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Wedbush Securities Inc holds 45,387 shares of ABT stock, worth $5.14 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
45,387
Previous 51,226 11.4%
Holding current value
$5.14 Million
Previous $5.32 Million 2.78%
% of portfolio
0.19%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$100.07 - $118.13 $584,308 - $689,761
-5,839 Reduced 11.4%
45,387 $5.18 Million
Q2 2024

Aug 06, 2024
BUY
$100.73 - $112.44 $451,371 - $503,843
4,481 Added 9.59%
51,226 $5.32 Million
Q1 2024

May 14, 2024
BUY
$109.52 - $120.96 $801,686 - $885,427
7,320 Added 18.57%
46,745 $5.31 Million
Q4 2023

Feb 12, 2024
BUY
$90.19 - $110.4 $59,525 - $72,864
660 Added 1.7%
39,425 $4.34 Million
Q3 2023

Nov 14, 2023
BUY
$95.53 - $114.62 $337,029 - $404,379
3,528 Added 10.01%
38,765 $3.75 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $147,138 - $163,943
1,460 Added 4.32%
35,237 $3.84 Million
Q1 2023

May 09, 2023
SELL
$96.86 - $114.01 $7,458 - $8,778
-77 Reduced 0.23%
33,777 $3.42 Million
Q4 2022

Jan 31, 2023
SELL
$95.06 - $111.52 $19,107 - $22,415
-201 Reduced 0.59%
33,854 $3.72 Million
Q3 2022

Oct 18, 2022
BUY
$96.76 - $112.03 $5,805 - $6,721
60 Added 0.18%
34,055 $3.3 Million
Q2 2022

Jul 21, 2022
SELL
$102.07 - $123.37 $5,613 - $6,785
-55 Reduced 0.16%
33,995 $3.69 Million
Q1 2022

Apr 19, 2022
SELL
$114.02 - $139.04 $134,657 - $164,206
-1,181 Reduced 3.35%
34,050 $4.03 Million
Q4 2021

Jan 13, 2022
SELL
$115.53 - $141.46 $111,948 - $137,074
-969 Reduced 2.68%
35,231 $4.96 Million
Q3 2021

Oct 08, 2021
BUY
$116.66 - $129.06 $16,215 - $17,939
139 Added 0.39%
36,200 $4.28 Million
Q2 2021

Jul 27, 2021
SELL
$105.79 - $124.53 $33,112 - $38,977
-313 Reduced 0.86%
36,061 $4.18 Million
Q1 2021

Apr 26, 2021
BUY
$108.84 - $128.23 $672,413 - $792,204
6,178 Added 20.46%
36,374 $4.36 Million
Q4 2020

Feb 16, 2021
BUY
$105.0 - $114.42 $126,315 - $137,647
1,203 Added 4.15%
30,196 $3.31 Million
Q3 2020

Oct 20, 2020
SELL
$91.64 - $111.29 $229,008 - $278,113
-2,499 Reduced 7.94%
28,993 $3.16 Million
Q2 2020

Jul 16, 2020
SELL
$76.57 - $98.0 $47,626 - $60,956
-622 Reduced 1.94%
31,492 $2.88 Million
Q1 2020

Apr 17, 2020
SELL
$62.82 - $91.86 $143,480 - $209,808
-2,284 Reduced 6.64%
32,114 $2.53 Million
Q4 2019

Jan 16, 2020
BUY
$78.51 - $87.4 $70,423 - $78,397
897 Added 2.68%
34,398 $2.99 Million
Q3 2019

Oct 17, 2019
BUY
$81.84 - $88.74 $312,546 - $338,898
3,819 Added 12.87%
33,501 $2.8 Million
Q2 2019

Aug 01, 2019
BUY
$72.88 - $85.0 $103,854 - $121,125
1,425 Added 5.04%
29,682 $2.5 Million
Q1 2019

Apr 17, 2019
BUY
$66.22 - $80.06 $43,241 - $52,279
653 Added 2.37%
28,257 $2.26 Million
Q4 2018

Jan 31, 2019
BUY
$65.56 - $74.27 $356,253 - $403,583
5,434 Added 24.51%
27,604 $2 Million
Q3 2018

Nov 13, 2018
SELL
$60.81 - $73.36 $43,965 - $53,039
-723 Reduced 3.16%
22,170 $1.63 Million
Q2 2018

Aug 03, 2018
SELL
$57.57 - $63.54 $2,130 - $2,350
-37 Reduced 0.16%
22,893 $1.4 Million
Q1 2018

May 01, 2018
SELL
$56.27 - $63.62 $33,593 - $37,981
-597 Reduced 2.54%
22,930 $1.37 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $30,973 - $33,160
-577 Reduced 2.39%
23,527 $1.34 Million
Q3 2017

Oct 31, 2017
BUY
$48.06 - $53.64 $1.16 Million - $1.29 Million
24,104
24,104 $1.29 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email